| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10307444 | Schizophrenia Research | 2014 | 8 Pages |
Abstract
Trajectories of treatment response to the psychopharmacological medication of the negative symptoms of schizophrenia demonstrate substantial heterogeneity. Approximately half of the patients included in our analysis showed little improvement, and the most severely ill at baseline responded the most.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Stephen Z. Levine, Stefan Leucht,